Riccardo Moia

50PUBLICATIONS
253CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Aug 17, 2026
Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience.

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Jun 08, 2026
Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial.

|May 14, 2026
Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53).

|Mar 04, 2026
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy.

Francesco Autore, Andrea Visentin, Candida Vitale

|Feb 18, 2026
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Chiara Cosentino, Samir Mouhssine, Antonella Zucchetto

Pageof 9

Frequent Collaborators

15 joint publications

Gianluca Gaidano

11 joint publications

Massimo Gentile

10 joint publications

Luca Laurenti

9 joint publications

Andrea Visentin